Tesamorelin / Ipamorelin Blend
Also known as: Tesa/Ipa · Tesamorelin + Ipamorelin
A GHRH analog studied for visceral fat (tesamorelin) paired with the GH secretagogue ipamorelin.
Tesamorelin / Ipamorelin Blend at a glance
| Name | Tesamorelin / Ipamorelin Blend |
|---|---|
| Also known as | Tesa/Ipa, Tesamorelin + Ipamorelin |
| Category | Growth-hormone axis |
| Type | Peptide |
| Sequence | Blend — not a single peptide (Tesamorelin + Ipamorelin). |
| Typical dose | By the vial's per-component mg (e.g. 12 mg tesamorelin / 3 mg ipamorelin) |
| Frequency | Often once daily |
| Route | Subcutaneous injection |
| Half-life | Both components are relatively short-acting. |
Overview
This blend pairs tesamorelin — a stabilized GHRH analog that is the one FDA-approved GHRH-type peptide, used clinically for HIV-associated visceral fat — with ipamorelin, a selective GH secretagogue. Sold pre-mixed (often at a ratio like 12 mg : 3 mg), it is marketed for growth-hormone support and body composition. The blended research product itself is not an approved medicine even though tesamorelin as a standalone drug is.
How it’s thought to work
- Tesamorelin acts as a GHRH analog and has clinical data for reducing visceral adipose tissue.
- Ipamorelin adds a selective GH pulse through the ghrelin/GHS receptor.
- The pairing aims to combine steady GHRH drive with a pulsatile secretagogue.
Researched uses
- Visceral fat reduction (tesamorelin component, clinical)
- Growth-hormone support
- Body-composition research
Commonly cited protocol
| Typical dose | By the vial's per-component mg (e.g. 12 mg tesamorelin / 3 mg ipamorelin) |
|---|---|
| Frequency | Often once daily |
| Route | Subcutaneous injection |
| Notes | Tesamorelin as a standalone is prescription-only; the blend is a research product. |
Reconstitution
Combined vial — reconstitute and use the blend calculator to find units per component.
Cautions
- The blended research product is not FDA-approved.
- GH-axis peptides affect endocrine function.
- Content and purity of research blends vary by source.
Tesamorelin / Ipamorelin Blend FAQ
What is Tesamorelin / Ipamorelin Blend?
A GHRH analog studied for visceral fat (tesamorelin) paired with the GH secretagogue ipamorelin.
How does Tesamorelin / Ipamorelin Blend work?
Tesamorelin acts as a GHRH analog and has clinical data for reducing visceral adipose tissue. Ipamorelin adds a selective GH pulse through the ghrelin/GHS receptor. The pairing aims to combine steady GHRH drive with a pulsatile secretagogue.
What is Tesamorelin / Ipamorelin Blend used for?
Visceral fat reduction (tesamorelin component, clinical); Growth-hormone support; Body-composition research.
What is a typical Tesamorelin / Ipamorelin Blend dose?
By the vial's per-component mg (e.g. 12 mg tesamorelin / 3 mg ipamorelin), Often once daily, Subcutaneous injection. This is a commonly cited figure for context only, not medical advice.
How do you reconstitute Tesamorelin / Ipamorelin Blend?
Combined vial — reconstitute and use the blend calculator to find units per component.
What is the half-life of Tesamorelin / Ipamorelin Blend?
Both components are relatively short-acting.